Delivery Order SPE2DB20D7061-SPE2DB25FSPT0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with a ceiling value of $1,592.69. This non-competitive, firm fixed price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,788.64 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with completion scheduled for September 22, 2025. This contract utilized firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a $1,912.48 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of September 10, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,666.01 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,765.26 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on June 9, 2025, with completion scheduled for June 10, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and was performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) with a ceiling value of $1,148.28. This is a firm fixed-price, non-set-aside contract utilizing a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This delivery order...
- The Defense Logistics Agency awarded a $9,408.60 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) under a firm fixed price contract type. The award, made on September 9, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order valued at $1,594.26 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a pharmaceutical product used for ear infections combining an antibiotic and corticosteroid. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by May 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 28, 2025. The award was made competitively without a set-aside designation and represents a child contract under AmerisourceBergen's...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPT0Delivery Order
The Defense Logistics Agency awarded a $14,675.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product is to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through its comprehensive IDC with the Defense Logistics Agency. The SPE2DX contract serves as a global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to support Department of Defense healthcare programs worldwide. This delivery order for the otic suspension medication represents one of numerous individual orders fulfilled under this expansive contract vehicle, demonstrating AmerisourceBergen's established capability to meet federal medical procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 9/15/25 |